292 related articles for article (PubMed ID: 32705966)
1. Pharmacogenomics of methadone: a narrative review of the literature.
Packiasabapathy S; Aruldhas BW; Horn N; Overholser BR; Quinney SK; Renschler JS; Sadhasivam S
Pharmacogenomics; 2020 Aug; 21(12):871-887. PubMed ID: 32705966
[No Abstract] [Full Text] [Related]
2. Pharmacogenetics of Methadone Response.
Fonseca F; Torrens M
Mol Diagn Ther; 2018 Feb; 22(1):57-78. PubMed ID: 29168075
[TBL] [Abstract][Full Text] [Related]
3. Switching Opioid-Dependent Patients From Methadone to Morphine: Safety, Tolerability, and Methadone Pharmacokinetics.
Glue P; Cape G; Tunnicliff D; Lockhart M; Lam F; Gray A; Hung N; Hung CT; Harland S; Devane J; Howes J; Weis H; Friedhoff L
J Clin Pharmacol; 2016 Aug; 56(8):960-5. PubMed ID: 26763764
[TBL] [Abstract][Full Text] [Related]
4. Metabolic and toxicological considerations of the opioid replacement therapy and analgesic drugs: methadone and buprenorphine.
Moody DE
Expert Opin Drug Metab Toxicol; 2013 Jun; 9(6):675-97. PubMed ID: 23537174
[TBL] [Abstract][Full Text] [Related]
5. Pharmacogenomics biomarkers for personalized methadone maintenance treatment: The mechanism and its potential use.
Ramli FF
Bosn J Basic Med Sci; 2021 Apr; 21(2):145-154. PubMed ID: 32841585
[TBL] [Abstract][Full Text] [Related]
6. Association of genetic variation in pharmacodynamic factors with methadone dose required for effective treatment of opioid addiction.
Levran O; Peles E; Randesi M; Shu X; Ott J; Shen PH; Adelson M; Kreek MJ
Pharmacogenomics; 2013 May; 14(7):755-68. PubMed ID: 23651024
[TBL] [Abstract][Full Text] [Related]
7. Genetic variants in NECTIN4 encoding an adhesion molecule are associated with continued opioid use.
Fang CP; Liu TH; Chung RH; Tsou HH; Kuo HW; Wang SC; Liu CC; Liu SC; Chen ACH; Liu YL
PLoS One; 2020; 15(6):e0234549. PubMed ID: 32555608
[TBL] [Abstract][Full Text] [Related]
8. Pharmacotherapy of neonatal opioid withdrawal syndrome: a review of pharmacokinetics and pharmacodynamics.
van Hoogdalem MW; McPhail BT; Hahn D; Wexelblatt SL; Akinbi HT; Vinks AA; Mizuno T
Expert Opin Drug Metab Toxicol; 2021 Jan; 17(1):87-103. PubMed ID: 33049155
[TBL] [Abstract][Full Text] [Related]
9. Methadone dose in heroin-dependent patients: role of clinical factors, comedications, genetic polymorphisms and enzyme activity.
Mouly S; Bloch V; Peoc'h K; Houze P; Labat L; Ksouda K; Simoneau G; Declèves X; Bergmann JF; Scherrmann JM; Laplanche JL; Lepine JP; Vorspan F
Br J Clin Pharmacol; 2015 Jun; 79(6):967-77. PubMed ID: 25556837
[TBL] [Abstract][Full Text] [Related]
10. Pharmacogenomics of methadone maintenance treatment.
Somogyi AA; Barratt DT; Ali RL; Coller JK
Pharmacogenomics; 2014 May; 15(7):1007-27. PubMed ID: 24956254
[TBL] [Abstract][Full Text] [Related]
11. Pharmacoepigenomics of opiates and methadone maintenance treatment: current data and perspectives.
Marie-Claire C; Jourdaine C; Lépine JP; Bellivier F; Bloch V; Vorspan F
Pharmacogenomics; 2017 Sep; 18(14):1359-1372. PubMed ID: 28841113
[TBL] [Abstract][Full Text] [Related]
12. Ethnic and genetic factors in methadone pharmacokinetics: a population pharmacokinetic study.
Bart G; Lenz S; Straka RJ; Brundage RC
Drug Alcohol Depend; 2014 Dec; 145():185-93. PubMed ID: 25456329
[TBL] [Abstract][Full Text] [Related]
13. [Improve the benefit/risk balance of methadone by respecting its pharmacological specificities].
Frauger E; Fouilhé Sam-Laï N; Mallaret M; Micallef J;
Therapie; 2019 Jun; 74(3):383-388. PubMed ID: 31178032
[TBL] [Abstract][Full Text] [Related]
14. Interindividual variability of methadone response: impact of genetic polymorphism.
Li Y; Kantelip JP; Gerritsen-van Schieveen P; Davani S
Mol Diagn Ther; 2008; 12(2):109-24. PubMed ID: 18422375
[TBL] [Abstract][Full Text] [Related]
15. The impact of OPRM1's genetic polymorphisms on methadone maintenance treatment in opioid addicts: a systematic review.
Oueslati B; Moula O; Ghachem R
Pharmacogenomics; 2018 Jun; 19(8):741-747. PubMed ID: 29785888
[TBL] [Abstract][Full Text] [Related]
16. Pharmacogenetics of opiates in clinical practice: the visible tip of the iceberg.
Hajj A; Khabbaz L; Laplanche JL; Peoc'h K
Pharmacogenomics; 2013 Apr; 14(5):575-85. PubMed ID: 23556453
[TBL] [Abstract][Full Text] [Related]
17. Peripartum Anesthetic Management of the Opioid-tolerant or Buprenorphine/Suboxone-dependent Patient.
Pan A; Zakowski M
Clin Obstet Gynecol; 2017 Jun; 60(2):447-458. PubMed ID: 28426507
[TBL] [Abstract][Full Text] [Related]
18. Medications for Opioid Use Disorder: A Guide for Physicians.
Azhar N; Chockalingam R; Azhar A
Mo Med; 2020; 117(1):59-64. PubMed ID: 32158052
[TBL] [Abstract][Full Text] [Related]
19. Effects of cytochrome P450 single nucleotide polymorphisms on methadone metabolism and pharmacodynamics.
Ahmad T; Valentovic MA; Rankin GO
Biochem Pharmacol; 2018 Jul; 153():196-204. PubMed ID: 29458047
[TBL] [Abstract][Full Text] [Related]
20. Interindividual variability of the clinical pharmacokinetics of methadone: implications for the treatment of opioid dependence.
Eap CB; Buclin T; Baumann P
Clin Pharmacokinet; 2002; 41(14):1153-93. PubMed ID: 12405865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
